Pierfrancesco Tassone Selected Research

Breast Neoplasms (Breast Cancer)

3/2024	Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience.
1/2019	Polymorphic Variants in NR1I3 and UGT2B7 Predict Taxane Neurotoxicity and Have Prognostic Relevance in Patients With Breast Cancer: A Case-Control Study.
5/2018	miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling.
5/2016	mTOR inhibitors, a new era for metastatic luminal HER2-negative breast cancer? A systematic review and a meta-analysis of randomized trials.
3/2016	Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
6/2014	Sphingosine analog fingolimod (FTY720) increases radiation sensitivity of human breast cancer cells in vitro.
5/2011	Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein.
4/2009	Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo.
5/2005	Differential sensitivity of BRCA1-mutated HCC1937 human breast cancer cells to microtubule-interfering agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierfrancesco Tassone Research Topics

Disease

104	Neoplasms (Cancer) 03/2024 - 04/2002
79	Multiple Myeloma 05/2024 - 10/2002
13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2023 - 05/2010
9	Breast Neoplasms (Breast Cancer) 03/2024 - 05/2005
9	Hematologic Neoplasms (Hematological Malignancy) 03/2020 - 12/2004
9	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 11/2011
7	Ovarian Neoplasms (Ovarian Cancer) 12/2023 - 10/2009
6	Neoplasm Metastasis (Metastasis) 01/2023 - 12/2011
6	Colonic Neoplasms (Colon Cancer) 06/2012 - 04/2003
5	Melanoma (Melanoma, Malignant) 01/2022 - 01/2020
4	Inflammation (Inflammations) 03/2024 - 06/2005
4	Ovarian Epithelial Carcinoma 12/2023 - 05/2016
4	Genomic Instability 01/2021 - 01/2019
4	Carcinoma (Carcinomatosis) 02/2020 - 07/2002
4	Bone Diseases (Bone Disease) 11/2017 - 07/2009
3	Waldenstrom Macroglobulinemia (Macroglobulinemia) 09/2022 - 07/2004
3	Disease Progression 11/2017 - 08/2014
3	Pancreatic Neoplasms (Pancreatic Cancer) 03/2016 - 10/2009
3	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 07/2009 - 07/2005
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 01/2021
2	Adenocarcinoma of Lung 01/2023 - 01/2018
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 06/2022 - 01/2021
2	Hypoxia (Hypoxemia) 12/2021 - 05/2014
2	Paraproteinemias (Monoclonal Gammopathy) 01/2021 - 01/2020
2	Rare Diseases (Rare Disease) 01/2021 - 03/2020
2	Lung Neoplasms (Lung Cancer) 11/2020 - 01/2019
2	Lymphoma (Lymphomas) 10/2020 - 07/2006
2	Pneumonia (Pneumonitis) 01/2020 - 05/2010
2	Prostatic Neoplasms (Prostate Cancer) 11/2016 - 12/2011
2	Fever (Fevers) 04/2016 - 09/2015
2	Arthralgia (Joint Pain) 04/2016 - 09/2015
2	Rhinitis 04/2016 - 09/2015
2	Stomach Neoplasms (Stomach Cancer) 03/2016 - 01/2015

Drug/Important Bio-Agent (IBA)

37	MicroRNAs (MicroRNA)IBA 08/2023 - 09/2012
16	Biomarkers (Surrogate Marker)IBA 03/2024 - 10/2007
12	Monoclonal AntibodiesIBA 03/2021 - 07/2006
11	Immune Checkpoint InhibitorsIBA 01/2022 - 11/2016
9	Long Noncoding RNAIBA 01/2023 - 01/2018
8	AntigensIBA 06/2022 - 04/2002
8	Bortezomib (Velcade)FDA Link 02/2019 - 07/2005
8	Gemcitabine FDA Link 04/2016 - 07/2008
7	LNA-i-miR-221IBA 05/2024 - 01/2014
7	PlatinumIBA 12/2023 - 04/2009
7	Proteins (Proteins, Gene)FDA Link 12/2021 - 04/2003
6	locked nucleic acidIBA 01/2023 - 01/2014
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2012
6	Dexamethasone (Maxidex)FDA LinkGeneric 10/2018 - 10/2002
6	Interleukin-6 (Interleukin 6)IBA 04/2013 - 10/2002
5	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2023 - 12/2011
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021 - 08/2008
5	EpitopesIBA 01/2020 - 05/2011
5	mouse MIRN29 microRNAIBA 12/2017 - 10/2012
5	Bevacizumab (Avastin)FDA Link 09/2017 - 05/2010
4	CytokinesIBA 03/2024 - 09/2007
4	Carboplatin (JM8)FDA LinkGeneric 12/2023 - 12/2016
4	NivolumabIBA 01/2022 - 07/2019
4	Messenger RNA (mRNA)IBA 01/2021 - 01/2005
4	Untranslated RNA (Noncoding RNA)IBA 01/2020 - 06/2013
4	Peptides (Polypeptides)IBA 01/2020 - 09/2015
4	EnzymesIBA 01/2020 - 09/2015
4	Cisplatin (Platino)FDA LinkGeneric 09/2017 - 04/2009
4	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2015 - 07/2008
4	Irinotecan (Camptosar)FDA LinkGeneric 06/2012 - 12/2004
4	Zoledronic Acid (Zometa)FDA Link 12/2011 - 10/2002
4	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2007 - 10/2002
3	Melphalan (Alkeran)FDA LinkGeneric 05/2024 - 08/2008
3	pembrolizumabIBA 01/2023 - 01/2020
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2014
3	AntibodiesIBA 03/2021 - 04/2016
3	Thymidylate SynthaseIBA 04/2018 - 09/2015
3	tetraphenylporphine sulfonate (TPPS)IBA 04/2018 - 09/2015
3	Etoposide (VP 16)FDA LinkGeneric 09/2017 - 05/2010
3	Interleukin-2 (IL2)IBA 04/2016 - 01/2014
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2016 - 05/2010
3	LipidsIBA 06/2014 - 01/2014
3	Fluorouracil (Carac)FDA LinkGeneric 01/2014 - 05/2010
3	ParaproteinsIBA 08/2005 - 07/2004
2	Trastuzumab (Herceptin)FDA Link 03/2024 - 03/2016
2	Cyclophilins (Cyclophilin)IBA 01/2024 - 06/2015
2	DNA Ligase ATPIBA 10/2022 - 01/2019
2	FlavonoidsIBA 10/2022 - 01/2020
2	Glycoproteins (Glycoprotein)IBA 06/2022 - 05/2011
2	IntegrinsIBA 01/2022 - 06/2011
2	Lenalidomide (CC 5013)FDA Link 08/2021 - 12/2009
2	PolyphenolsIBA 01/2020 - 07/2019
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 08/2019 - 12/2004
2	Proteasome Endopeptidase Complex (Proteasome)IBA 02/2019 - 01/2018
2	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 01/2019 - 11/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2018 - 07/2005
2	VaccinesIBA 04/2018 - 09/2015
2	Tumor Biomarkers (Tumor Markers)IBA 11/2017 - 01/2014
2	Endothelial Growth FactorsIBA 09/2017 - 05/2010
2	Histones (Histone)IBA 01/2017 - 05/2015
2	Protein Subunit VaccinesIBA 04/2016 - 09/2015
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2016 - 11/2006

Therapy/Procedure

30	Therapeutics 01/2023 - 12/2004
16	Drug Therapy (Chemotherapy) 01/2022 - 05/2010
10	Immunotherapy 01/2023 - 04/2016
6	Radiotherapy 03/2023 - 07/2006
4	Aftercare (After-Treatment) 01/2022 - 12/2004